Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor Cancer × Carboplatin × Other solid neoplasm × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Retinoblastoma 20 Advanced Solid Tumors 16 Mesothelioma 15 Mesothelioma, Malignant 14 Unspecified Adult Solid Tumor, Protocol Specific 13 Solid Tumors 9 Advanced Solid Tumor 7 Unspecified Childhood Solid Tumor, Protocol Specific 3 Solid Tumor 3 Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Solid Tumor, Adult 2 Sarcoma 2 Retinal Neoplasms 2 Relapsed Pediatric Solid Tumor 2 Ovarian Neoplasms 2 Neuroblastoma 2 Medulloblastoma 2 Central Nervous System Neoplasms 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Advanced Solid Tumours 2 Wilms Tumor 1 Uveal Melanoma 1 Uterine Neoplasms 1 Unspecified Adult Solid Tumor - Protocol Specific 1 Unresectable Locally Advanced or Metastatic Solid Tumors 1 Triple Negative Metastatic Breast Cancer 1 Triple Negative Breast Neoplasms 1 Thrombocytopenia 1

Interventions

ispinesib 2 trametinib 1 irinotecan sucrosofate 1 Vincristine 1 Temozolomide 1 TP protocol 1 Pemetrexed 1 Paclitaxel 1 PE regimen 1 Interleukin-18 1 Immunotherapy 1 Imatinib Mesylate 1 Docetaxel 1 Cisplatin 1 Carboplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06649448 2024-10-18

EF-001

Shandong Cancer Hospital and Institute

Phase NA Not yet recruiting

Other solid neoplasm

Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡